Schizophrenia Research and Treatment / 2013 / Article / Tab 2

Clinical Study

Cognitive Training for Schizophrenia in Developing Countries: A Pilot Trial in Brazil

Table 2

Results at after intervention in the CT and control groups and effect-sizes.

mean ± SE
mean ± SE
Between groups
Within groups
Interaction Effect-size

Positive and negative syndrome scale for schizophrenia
Negative subscale
 Baseline 0.3030.3580.7530.877
Positive subscale
 Baseline 0.6100.0120.9350.000
General psychopathology subscale
 Baseline 0.5760.0440.5810.486
Total score
 Baseline 0.5990.2750.7600.263

Neuropsychological measures
Trail Making A
 Baseline 0.9030.0030.0190.821
Trail Making B
 Baseline 0.9000.0450.4270.272
Stroop Test Card I
 Baseline 0.7560.3430.7990.691
Stroop Test Card II
 Baseline 0.3340.0010.9300.015
Stroop Test Card III
 Baseline 0.9580.5530.0361.549
MWCST total categories
 Baseline 0.562 0.4780.0671.177
MWCST perseverative errors
 Baseline 0.5490.0460.3950.134
MWCST failure to maintain set
 Baseline 0.7020.7450.0101.086
Logical memory I
 Baseline 0.8540.4680.6800.199
Logical memory II
 Baseline 0.8020.6430.0031.618
Visual reproduction I
 Baseline 0.3780.1570.4040.261
Visual reproduction II
 Baseline 0.0530.0720.1031.127

Interaction: groups time.
SE: standard error.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.